Position in GILD
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$176,239,776
+$67,100,964 QoQ
Shares Held
1,264,546
+42.2% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $5,990,626,556 across 6 Drug Manufacturers - General names. GILD ranks #4 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,060,878 | $4,654,843,757 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,249,337 | $751,732,746 | |
| 3 | ABBV |
AbbVie Inc.
|
1,062,732 | $231,133,582 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
1,264,546 | $176,239,776 | |
| 5 | AZN |
Astrazeneca PLC
|
663,945 | $130,943,232 | |
| 6 | AMGN |
Amgen Inc
|
129,980 | $45,733,463 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $176,239,776 | 1,264,546 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $109,138,812 | 889,187 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $16,443,873 | 148,143 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $71,770,253 | 647,337 | Shares | Defined | 2025-08-01 | |
| 2024-12-31 | $87,162,918 | 943,628 | Shares | Defined | 2025-01-24 | |
| 2021-03-31 | $34,906,856 | 540,103 | Shares | Defined | 2021-05-11 | |
| 2020-03-31 | $1,613,844 | 21,587 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||